Stocks / NASDAQ / GeoVax Labs Inc.

GeoVax Labs Inc.

Our Opinion

GeoVax Labs Inc. is on the Cruelty Free Investing use of animals list because they conduct pre-clinical studies of their drugs on animals to assess a product’s safety profile.

Supporting Evidence:

The company stated in the following report that they exploit animals for product testing.

“Our small animal studies are continuing, with results expected later this year, and based on results we’ve seen thus far, we recently submitted an application to NIH for additional support for advanced testing, with this goal in mind.” (Page 3) Read the full document

Company Description

GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and cancers using modified vaccinia ankara virus-like particle vaccine platform. It is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhagic fever viruses, such as Ebola, Sudan, Marburg, and Lassa, as well as therapeutic vaccines for HIV, chronic Hepatitis B infections, and solid tumor cancers.

Company Website: